Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scazziota

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Circulation|December 1, 1996
Why aspirin cannot prevent arterial thrombosisR Altman, A Scazziota
Thrombosis Research|July 1, 1986
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intakeR Altman, A Scazziota
Haemostasis|July 27, 1999
Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitorR Altman, A Scazziota, J Rouvier
Circulation|January 27, 1998
Daily 50 mg or 500 mg aspirin does not affect the cooperation of arachidonic acid and ADP on platelet aggregationR Altman, A Scazziota, J Rouvier
Clinical Pharmacology and Therapeutics|September 1, 1988
Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregationR Altman, A Scazziota, C Dujovne
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Secondary prevention of myocardial infarction: beneficial effect of combining oral anticoagulant plus aspirin: therapy based on evidenceR Altman, J Rouvier, A Scazziota
Thrombosis Research|August 1, 1988
Why single daily dose of aspirin may not prevent platelet aggregationR Altman, A Scazziota, J C Funes
Thrombosis and Haemostasis|January 12, 2001
Effect of sodium arachidonate on thrombin generation through platelet activation--inhibitory effect of aspirinR Altman, A Scazziota, J Rouvier, et al.
Thrombosis Research|July 1, 1986
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasmaR Altman, A Scazziota, J Rouvier, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activityR Altman, A Scazziota, J Rouvier, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Circulation|December 1, 1996
Why aspirin cannot prevent arterial thrombosisR Altman, A Scazziota
Thrombosis Research|July 1, 1986
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intakeR Altman, A Scazziota
Haemostasis|July 27, 1999
Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitorR Altman, A Scazziota, J Rouvier
Circulation|January 27, 1998
Daily 50 mg or 500 mg aspirin does not affect the cooperation of arachidonic acid and ADP on platelet aggregationR Altman, A Scazziota, J Rouvier
Clinical Pharmacology and Therapeutics|September 1, 1988
Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregationR Altman, A Scazziota, C Dujovne
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Secondary prevention of myocardial infarction: beneficial effect of combining oral anticoagulant plus aspirin: therapy based on evidenceR Altman, J Rouvier, A Scazziota
Thrombosis Research|August 1, 1988
Why single daily dose of aspirin may not prevent platelet aggregationR Altman, A Scazziota, J C Funes
Thrombosis and Haemostasis|January 12, 2001
Effect of sodium arachidonate on thrombin generation through platelet activation--inhibitory effect of aspirinR Altman, A Scazziota, J Rouvier, et al.
Thrombosis Research|July 1, 1986
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasmaR Altman, A Scazziota, J Rouvier, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activityR Altman, A Scazziota, J Rouvier, et al.
Pageof 2